Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Ryan Bjordahl"'
Autor:
Jeffrey S Miller, Martin Hosking, Ryan Bjordahl, Bahram Valamehr, Soheila Shirinbak, Zachary Davis, Bryan Hancock, Bruce Walcheck, Kristin M Snyder, Kate J Dixon, Geoffrey Hart, Melissa Khaw, Anders Matson, Jianming Wu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 12 (2023)
Background Antibody therapies can direct natural killer (NK) cells to tumor cells, tumor-associated cells, and suppressive immune cells to mediate antibody-dependent cell-mediated cytotoxicity (ADCC). This antigen-specific effector function of human
Externí odkaz:
https://doaj.org/article/5fb4875136e348289f045144cde7592c
Autor:
Frank Cichocki, Ryan Bjordahl, Jodie P. Goodridge, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour, Zachary B. Davis, Aimee Merino, Katie Tuininga, Hongbo Wang, Akhilesh Kumar, Brian Groff, Alec Witty, Greg Bonello, Janel Huffman, Thomas Dailey, Tom T. Lee, Karl-Johan Malmberg, Bruce Walcheck, Uta Höpken, Armin Rehm, Bahram Valamehr, Jeffrey S. Miller
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-15 (2022)
The use of chimeric antigen receptor modified immune cell therapeutics has improved the treatment of a range of tumours. Here the authors explore a dual-target iPSC-derived NK cell product as a potential therapeutic for the treatment of multiple myel
Externí odkaz:
https://doaj.org/article/cf51e4650f724761987dbfd84d67e91a
Autor:
Jeffrey Miller, Tom Lee, Ryan Bjordahl, Frank Cichocki, Jianfang Ning, Zachary Davis, Katie Tuininga, Hongbo Wang, Paul Rogers, Moyar Ge, Bob Valamehr, Clark Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/7e590c8269394cfcbf37a33cdf6a8df5
Autor:
Tom Lee, John Goulding, Mochtar Pribadi, Robert Blum, Wen-I Yeh, Yijia Pan, Svetlana Gaidarova, Chia-Wei Chang, Hui-Yi Chu, Ellen Liu, Shohreh Sikaroodi, Lucas Ferrari de Andrade, Lauren Fong, Janel Huffman, Ryan Bjordahl, Kai Wucherpfennig, Bahram Valamehr
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/dc7d6b71029847c78280719e191b744e
Autor:
Jeffrey Miller, Tom Lee, Ryan Bjordahl, Frank Cichocki, Jianfang Ning, Zachary Davis, Katie Tuininga, Hongbo Wang, Paul Rogers, Moyar Ge, Bob Valamehr, Clark Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/3aa43b6ddf544eb3908effa905139b90
Autor:
Frank Cichocki, Jodie P. Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B. Davis, Svetlana Gaidarova, Ramzey Abujarour, Brian Groff, Alec Witty, Hongbo Wang, Katie Tuininga, Behiye Kodal, Martin Felices, Greg Bonello, Janel Huffman, Thomas Dailey, Tom T. Lee, Bruce Walcheck, Bahram Valamehr, Jeffrey S. Miller
Publikováno v:
Blood. 140:2451-2462
Substantial numbers of B cell leukemia and lymphoma patients relapse due to antigen loss or heterogeneity after anti-CD19 chimeric antigen receptor (CAR) T cell therapy. To overcome antigen escape and address antigen heterogeneity, we engineered indu
Autor:
John Goulding, Wen-I Yeh, Bryan Hancock, Robert Blum, Tianhao Xu, Bi-Huei Yang, Chia-Wei Chang, Brian Groff, Earl Avramis, Mochtar Pribadi, Yijia Pan, Hui-Yi Chu, Shohreh Sikaroodi, Lauren Fong, Nicholas Brookhouser, Thomas Dailey, Miguel Meza, Matthew Denholtz, Evelyn Diaz, Judy Martin, Peter Szabo, Sarah Cooley, Lucas Ferrari de Andrade, Tom T. Lee, Ryan Bjordahl, Kai W. Wucherpfennig, Bahram Valamehr
Publikováno v:
Med.
Autor:
Jeffrey S. Miller, Sarah Cooley, Scott Wolchko, Bruce R. Blazar, Yenan T. Bryceson, Daniel Shoemaker, Stewart Abbot, Heinrich Schlums, Emily Taras, Dhifaf Sarhan, Peter Howard, Valarie McCullar, Phillip Dougherty, Katie Tuininga, Stacey Moreno, Svetlana Gaidarova, Paul Rogers, Betsy Rezner, Bin Zhang, Ryan Bjordahl, Bahram Valamehr, Frank Cichocki
This supplementary file contains Supplemental Figures 1-6. Supplemental Figure 1 shows that 7-day ex vivo culture of NK cells with IL-15 and 5 μM CHIR99021 leads to an increase in the frequencies of NK cells with heterogeneous adaptive NK cell pheno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::184b0fb84c9ccf8c3dc8884bfbd7510a
https://doi.org/10.1158/0008-5472.22414707
https://doi.org/10.1158/0008-5472.22414707
Autor:
Jeffrey S. Miller, Sarah Cooley, Scott Wolchko, Bruce R. Blazar, Yenan T. Bryceson, Daniel Shoemaker, Stewart Abbot, Heinrich Schlums, Emily Taras, Dhifaf Sarhan, Peter Howard, Valarie McCullar, Phillip Dougherty, Katie Tuininga, Stacey Moreno, Svetlana Gaidarova, Paul Rogers, Betsy Rezner, Bin Zhang, Ryan Bjordahl, Bahram Valamehr, Frank Cichocki
Maturation of human natural killer (NK) cells as defined by accumulation of cell-surface expression of CD57 is associated with increased cytotoxic character and TNF and IFNγ production upon target-cell recognition. Notably, multiple studies point to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::85658b7abe87652af3f076650f779e3e
https://doi.org/10.1158/0008-5472.c.6509055.v1
https://doi.org/10.1158/0008-5472.c.6509055.v1
Autor:
Martin Gutierrez, Melissa Johnson, David Sommerhalder, Wells Messersmith, Haeseong Park, Muhammad Furqan, Jason Chesney, Ryan Bjordahl, Lingmin Zeng, Peter Szabo, Yu-Waye Chu, Brandon Beagle, Bob Valamehr, Jeffrey Chou, David Hong
Publikováno v:
Regular and Young Investigator Award Abstracts.